The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
117823043 11782304 3 F 20150709 20160811 20151127 20160815 EXP ES-AMGEN-ESPCT2015125696 AMGEN 64.00 YR A M Y 63.00000 KG 20160815 MD ES ES

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
117823043 11782304 1 PS denosumab DENOSUMAB 1 Subcutaneous 120 MG, Q3WK 125320 120 MG SOLUTION FOR INJECTION Q3W
117823043 11782304 2 SS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) 500 MG, Q3WK 0 500 MG Q3W
117823043 11782304 3 SS GEMCITABINE GEMCITABINEGEMCITABINE HYDROCHLORIDE 1 Intravenous (not otherwise specified) 2200 MG, 8 OF THREE WEEK CYCLE. 0 2200 MG
117823043 11782304 4 C CALCIUM CALCIUM 1 Oral 500 MG, QD 0 500 MG QD
117823043 11782304 5 C CALCIUM CALCIUM 1 0
117823043 11782304 6 C DEXAMETHASONE. DEXAMETHASONE 1 Oral 4 UNK, UNK 0 4 MG TID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
117823043 11782304 1 Non-small cell lung cancer stage IV
117823043 11782304 2 Non-small cell lung cancer stage IV
117823043 11782304 3 Non-small cell lung cancer stage IV
117823043 11782304 4 Metastases to bone
117823043 11782304 5 Hypocalcaemia
117823043 11782304 6 Neoplasm malignant

Outcome of event

Event ID CASEID OUTC COD
117823043 11782304 LT
117823043 11782304 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
117823043 11782304 Hypocalcaemia
117823043 11782304 Pyrexia

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
117823043 11782304 1 20150616 0
117823043 11782304 2 20150616 0
117823043 11782304 3 20150616 0
117823043 11782304 4 20150616 201509 0
117823043 11782304 6 20150527 0